The Value of ADAMTS13 in Predicting Clinical Outcomes in Patients With Acute Ischemic Stroke Receiving Thrombolysis

The Value of ADAMTS13 in Predicting Clinical Outcomes in Patients With Acute Ischemic Stroke Receiving Thrombolysis

Objective: To determine the association between baseline ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) antigen level and 90-days clinical outcome in patients with acute ischemic stroke (AIS) receiving recombinant tissue plasminogen activator (rt-PA) thr...

Full description

Bibliographic Details
Main Authors: Ya Su, Xin Chen, Xiaofei Ye, Haiyan Sun, Fei Wu, Qiang Dong, Xin Cheng, Danhong Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Neurology
Subjects:
ADAMTS13
ischemic stroke
thrombolysis
clinical outcome
hemorrhagic transformation
infarct core
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00799/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00799/full

Similar Items